About The Study: The 2024 long COVID research index for adults builds on the 2023 index with additional data and symptoms to help researchers classify symptomatic long COVID and its symptom subtypes. Continued future refinement of the index will be needed as the understanding of long COVID evolves.
Corresponding Author: To contact the corresponding author, Leora I. Horwitz, MD, MHS, email leora.horwitz@nyulangone.org.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2024.24184)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.24184?guestAccessKey=77bdd800-1217-41f0-bada-33a43d62bde1&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121824
Journal
JAMA